Cargando…
Recent Advances and Future Directions in Downstream Processing of Therapeutic Antibodies
Despite the advent of many new therapies, therapeutic monoclonal antibodies remain a prominent biologics product, with a market value of billions of dollars annually. A variety of downstream processing technological advances have led to a paradigm shift in how therapeutic antibodies are developed an...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369434/ https://www.ncbi.nlm.nih.gov/pubmed/35955796 http://dx.doi.org/10.3390/ijms23158663 |